Posted by: admin on: April 28, 2011
Clinicians do not lack for alternative therapies if patients with type 2 diabetes ask to be switched from rosiglitazone (Avandia, GlaxoSmithKline) to another glucose-lowering medication, according to the American Diabetes Association (ADA) and 2 other expert groups. The drug is again under increased scrutiny over cardiovascular risks. Dr. Bergenstal, who also is executive director of […]
Posted by: admin on: April 28, 2011
Chronic daily headache (CDH) is a descriptive term that encompasses several different headache diagnoses. Epidemiology: Chronic daily headache affects 4% of the adult population in the United States and around the world. The vast majority of CDH patients suffer from either chronic migraine or chronic tension-type headache. Chronic daily headache results in significant pain and […]
Posted by: admin on: April 28, 2011
The first overhaul in four years of the American Heart Association guidelines on cardiovascular disease prevention in women has lowered the threshold for who is considered “high risk,” “There have been a couple of major changes,” she notes. “As well as the lowering of this threshold, we also focus on what can be accomplished in […]